Filing Details
- Accession Number:
- 0001562180-22-002063
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-01 20:13:19
- Reporting Period:
- 2022-02-25
- Accepted Time:
- 2022-03-01 20:13:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1603756 | Axonics Inc. | AXNX | Surgical & Medical Instruments & Apparatus (3841) | 454744083 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1756438 | L. Danny Dearen | 26 Technology Drive Irvine CA 92618 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-02-25 | 6,421 | $25.82 | 34,656 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-02-25 | 3,579 | $14.19 | 38,235 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-02-25 | 10,000 | $57.00 | 28,235 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to buy) | Disposition | 2022-02-25 | 6,421 | $0.00 | 6,421 | $25.82 |
| Common Stock | Stock Options (Right to buy) | Disposition | 2022-02-25 | 3,579 | $0.00 | 3,579 | $14.19 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 14,672 | 2029-12-12 | No | 4 | M | Direct | |
| 6,666 | 2029-01-30 | No | 4 | M | Direct |
Footnotes
- The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on December 12, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on December 1, 2023, provided the reporting person remains in continuous service on each vesting date.
- The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 1, 2023, provided the reporting person remains in continuous service on each vesting date.
Billionaire Hedge Funds
